Synapsa™ is a breakthrough new extract of a Bacopa monnieri, a tradition-honored botanical used by herbalists of the Far East who observed its beneficial effects on memory and mood centuries ago. Numerous scientific papers have been published on Bacopa over the last few decades as researchers have tested its ability to support cognitive function in both open-label and placebo-controlled clinical trials. In six double-blind, placebo-controlled clinical studies, healthy adults using Synapsa™ showed significantly improved performance in areas such as visual processing, learning rate, working memory, information retention and mental performance in cognitively demanding environments.*

Studies show support for two distinct types of benefit from Synapsa™ Memory Support: daily, long-term use (chronic) to enhance learning and memory, and short-term use (acute) to improve mental performance in cognitively demanding environments such as test-taking. In addition, the majority of studies behind Synapsa™ have been conducted on healthy adult subjects between age 18 and 65.*

Each serving of Memory500™ provides 320 mg of Synapsa™, the same amount given to research subjects in these published studies.

The most intriguing studies include:

A double-blind, placebo controlled trial in subjects 18 to 60 years of age consuming 300 mg per day of Synapsa™ showed a statistically significant improvement in speed of visual information processing, learning rate and memory consolidation. A statistically significant reduction in the rate of forgetting was also observed. (Stough C, Lloyd J, et al. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology 2001; 156:481-484.

A randomized, double-blind, placebo-controlled 12-week trial demonstrated a significant effect of Synapsa™ (300mg per day) on the retention of new information by participants 40 to 65 years of age.(Roodenrys S, Booth D, et al. Chronic effects of Brahmi (Bacopa monniera) on human memory. Neuropsychopharmacology 2002; 27:279-81.)

In another randomized double-blind, placebo-controlled 90-day trial, 62 participants ages 18-60 who took 300 mg of Synapsa™ daily demonstrated a statistically significant improvement in working memory, visual information processing (sustained attention) and accuracy in complex cognitive tasks. (Stough C, Downey LA, et al. Examining the nootropic effects of a special extract of Bacopa monniera on human cognitive functioning: a 90 day double-blind, placebo-controlled randomized trial. Phytotherapy Research 2008; 22:1629-34.)